Cargando…

Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.

The atypical mole syndrome (AMS) phenotype, characterised by a large number of common naevi as well as atypical naevi, has been described in families with a genetic susceptibility to melanoma. However, the importance of this phenotype for melanoma in the general population has not been conclusively...

Descripción completa

Detalles Bibliográficos
Autores principales: Bataille, V., Bishop, J. A., Sasieni, P., Swerdlow, A. J., Pinney, E., Griffiths, K., Cuzick, J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074531/
https://www.ncbi.nlm.nih.gov/pubmed/8664138
_version_ 1782137986566062080
author Bataille, V.
Bishop, J. A.
Sasieni, P.
Swerdlow, A. J.
Pinney, E.
Griffiths, K.
Cuzick, J.
author_facet Bataille, V.
Bishop, J. A.
Sasieni, P.
Swerdlow, A. J.
Pinney, E.
Griffiths, K.
Cuzick, J.
author_sort Bataille, V.
collection PubMed
description The atypical mole syndrome (AMS) phenotype, characterised by a large number of common naevi as well as atypical naevi, has been described in families with a genetic susceptibility to melanoma. However, the importance of this phenotype for melanoma in the general population has not been conclusively determined. This study was designed to examine the types and distribution of naevi as well as the prevalence of the AMS phenotype in melanoma patients in England compared with controls. A total of 426 cutaneous melanoma cases (61% of all incident cases) aged 16-75 years were recruited between 1989 and 1993 from the north-east Thames region of the UK and 416 controls from the same age group were recruited over the same period and from the same region. Each subject answered a questionnaire covering demographic details, sun exposure history and other risk factors and underwent a skin examination with total body naevus count performed by a dermatologist. The AMS phenotype was defined using a scoring system. Atypical naevi gave the highest relative risk for cutaneous melanoma, with an odds ratio (OR) of 28.7 (P < 0.0001) for four or more atypical naevi compared with none. Many common naevi were also an important risk factor: the OR for 100 or more naevi 2 mm or above in diameter compared with 0-4 naevi was 7.7 (P < 0.0001). Melanoma was also associated with naevi on sun-exposed sites but also with naevi on non-sun-exposed sites such as the dorsum of the feet, buttocks and anterior scalp. Sixteen per cent of the cases had the AMS phenotype compared with 2% of the controls (OR 10.4, P < 0.0001). The AMS phenotype was more common in males than females (P = 0.008). The odds ratio for the presence of the AMS phenotype was dependent on age, with an odds ratio of 16.1 (95% CI 4.6-57.5) for the presence of the AMS phenotype if aged less than 40 compared with an odds ratio of 6.9 (95% CI 2.9-16.6) if aged 40 or more. The AMS phenotype was strongly predictive of an increased risk of melanoma outside the familial context.
format Text
id pubmed-2074531
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20745312009-09-10 Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Bataille, V. Bishop, J. A. Sasieni, P. Swerdlow, A. J. Pinney, E. Griffiths, K. Cuzick, J. Br J Cancer Research Article The atypical mole syndrome (AMS) phenotype, characterised by a large number of common naevi as well as atypical naevi, has been described in families with a genetic susceptibility to melanoma. However, the importance of this phenotype for melanoma in the general population has not been conclusively determined. This study was designed to examine the types and distribution of naevi as well as the prevalence of the AMS phenotype in melanoma patients in England compared with controls. A total of 426 cutaneous melanoma cases (61% of all incident cases) aged 16-75 years were recruited between 1989 and 1993 from the north-east Thames region of the UK and 416 controls from the same age group were recruited over the same period and from the same region. Each subject answered a questionnaire covering demographic details, sun exposure history and other risk factors and underwent a skin examination with total body naevus count performed by a dermatologist. The AMS phenotype was defined using a scoring system. Atypical naevi gave the highest relative risk for cutaneous melanoma, with an odds ratio (OR) of 28.7 (P < 0.0001) for four or more atypical naevi compared with none. Many common naevi were also an important risk factor: the OR for 100 or more naevi 2 mm or above in diameter compared with 0-4 naevi was 7.7 (P < 0.0001). Melanoma was also associated with naevi on sun-exposed sites but also with naevi on non-sun-exposed sites such as the dorsum of the feet, buttocks and anterior scalp. Sixteen per cent of the cases had the AMS phenotype compared with 2% of the controls (OR 10.4, P < 0.0001). The AMS phenotype was more common in males than females (P = 0.008). The odds ratio for the presence of the AMS phenotype was dependent on age, with an odds ratio of 16.1 (95% CI 4.6-57.5) for the presence of the AMS phenotype if aged less than 40 compared with an odds ratio of 6.9 (95% CI 2.9-16.6) if aged 40 or more. The AMS phenotype was strongly predictive of an increased risk of melanoma outside the familial context. Nature Publishing Group 1996-06 /pmc/articles/PMC2074531/ /pubmed/8664138 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Bataille, V.
Bishop, J. A.
Sasieni, P.
Swerdlow, A. J.
Pinney, E.
Griffiths, K.
Cuzick, J.
Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.
title Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.
title_full Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.
title_fullStr Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.
title_full_unstemmed Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.
title_short Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.
title_sort risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074531/
https://www.ncbi.nlm.nih.gov/pubmed/8664138
work_keys_str_mv AT bataillev riskofcutaneousmelanomainrelationtothenumberstypesandsitesofnaeviacasecontrolstudy
AT bishopja riskofcutaneousmelanomainrelationtothenumberstypesandsitesofnaeviacasecontrolstudy
AT sasienip riskofcutaneousmelanomainrelationtothenumberstypesandsitesofnaeviacasecontrolstudy
AT swerdlowaj riskofcutaneousmelanomainrelationtothenumberstypesandsitesofnaeviacasecontrolstudy
AT pinneye riskofcutaneousmelanomainrelationtothenumberstypesandsitesofnaeviacasecontrolstudy
AT griffithsk riskofcutaneousmelanomainrelationtothenumberstypesandsitesofnaeviacasecontrolstudy
AT cuzickj riskofcutaneousmelanomainrelationtothenumberstypesandsitesofnaeviacasecontrolstudy